NeuroSense Therapeutics Ltd. Adjustments to Additional Paid in Capital, Other
NeuroSense Therapeutics Ltd. (NRSN) had Adjustments to Additional Paid in Capital, Other of $1.43 million as of 2024-12-17, per its 20-F filed 2026-03-31.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-03-31
- 2024-12-17: Adjustments to Additional Paid in Capital, Other $1.43M.
| Period end | Adjustments to Additional Paid in Capital, Other |
|---|---|
| 2024-12-17 | $1.43M 20-F · filed 2026-03-31 |